ey0019.4-4 | Important for clinical practice | ESPEYB19
HH Shukur
, L Hussain-Alkhateeb
, Farholt S
, O Norregaard
, AP Jorgensen
, C Hoybye
The Journal of Clinical Endocrinology & Metabolism, 2021, Vol. 106, No. 9, e3634e3643PMID: 33950234Brief Summary: This trial explored the effects of rhGH treatment in patients with Prader-Willi syndrome (PWS) on respiratory and sleep parameters. The trial was randomized and placebo-controlled for 1 year, followed by a 2-year, open-phase GH treatment period. Polysomnography performed every 6 months revealed no adverse effects of rhGH tr...